Annexon Inc (ANNX)
Healthcare
Biotechnology
5.10 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Annexon Inc (ANNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -47 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36 | -28 | -23 | -28 | -22 | -32 | -36 | -50 | -38 | -52 | -46 | -47 | -183 | |
| 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 2.2 | |
| 4.7 | 4.5 | 4.4 | 4.7 | 4.9 | 4.6 | 5.2 | 5.1 | 4.2 | 3.8 | 3.3 | 4.2 | 16 | |
| 4.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.9 | -0.6 | -0.5 | -7.5 | 3.9 | 0.4 | 9.5 | 0.2 | 7.2 | -1.7 | -1.5 | -7.1 | -3.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 5.5 | 48 | -2.2 | -77 | -97 | -46 | 1.0 | 98 | 73 | 46 | -27 | 27 | 119 | |
| – | – | – | – | – | – | – | – | – | – | 1.9 | – | – | |
| 0.3 | 9,335 | -9,335 | – | – | – | – | – | – | – | – | – | – | |
| 0.3 | 9,335 | 118 | 32 | 124 | 0.2 | 5.0 | 0.1 | 0.2 | 14 | 95 | 33 | 142 | |
| -31 | 20 | 92 | -73 | 5.4 | -78 | -30 | 48 | 35 | 7.1 | 23 | 13 | 78 | |
| -36 | -28 | -23 | -28 | -22 | -32 | -36 | -50 | -38 | -52 | -46 | -47 | -183 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.